Healthcare >> CEO Interviews >> October 26, 2004

Richard Powers – Corgentech Inc (cgtk)

RICHARD P. POWERS joined Corgentech Inc. as Vice President and Chief Financial Officer in October 2001. Previously, Mr. Powers served as Executive Vice President and Chief Financial Officer at Eclipse Surgical Technologies, where he led the effort to restructure the company following its merger with CardioGenesis Corporation. In addition to his responsibilities as CFO, he also managed all international sales and marketing operations. Prior to the merger with Eclipse, he served as Executive Vice President and Chief Financial Officer at CardioGenesis, where he was responsible for all administrative functions, international operations and US sales. He was also responsible for completing that company's successful initial public offering in 1996. Before joining CardioGenesis, Mr. Powers served as Senior Vice President and Chief Financial Officer at Syntex Corporation. During his nearly 15 years at Syntex, he oversaw Syntex's 700-person worldwide financial and administrative functions, and played an integral role in negotiating the sale of Syntex to Roche in 1994. He also currently serves on the Board of Directors of Airlease LTD and Mongonet Corporation. Mr. Powers received a Master of Business Administration degree from University of Rochester, New York. He earned a Bachelor's degree in Accounting at Canisius College in Buffalo, New York. Profile
TWST: Can you give us a brief overview of what Corgentech does?

Mr. Powers: Corgentech Inc. is a biopharmaceutical company focused on

the discovery, development and commercialization of a new